- Home
- TTC vs ROIV Comparison
TTC vs ROIV Comparison
Compare TTC & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTC
- ROIV
- Stock Information
- Founded
- TTC 1914
- ROIV 2014
- Country
- TTC United States
- ROIV United Kingdom
- Employees
- TTC N/A
- ROIV N/A
- Industry
- TTC Tools/Hardware
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- TTC Consumer Discretionary
- ROIV Health Care
- Exchange
- TTC Nasdaq
- ROIV Nasdaq
- Market Cap
- TTC 7.0B
- ROIV 7.8B
- IPO Year
- TTC N/A
- ROIV N/A
- Fundamental
- Price
- TTC $75.10
- ROIV $11.40
- Analyst Decision
- TTC Hold
- ROIV Buy
- Analyst Count
- TTC 4
- ROIV 4
- Target Price
- TTC $82.00
- ROIV $17.50
- AVG Volume (30 Days)
- TTC 940.8K
- ROIV 7.9M
- Earning Date
- TTC 09-04-2025
- ROIV 08-07-2025
- Dividend Yield
- TTC 2.02%
- ROIV N/A
- EPS Growth
- TTC 54.24
- ROIV N/A
- EPS
- TTC 3.89
- ROIV N/A
- Revenue
- TTC $4,545,800,000.00
- ROIV $29,053,000.00
- Revenue This Year
- TTC N/A
- ROIV $3.28
- Revenue Next Year
- TTC $3.15
- ROIV $156.84
- P/E Ratio
- TTC $19.35
- ROIV N/A
- Revenue Growth
- TTC 2.94
- ROIV N/A
- 52 Week Low
- TTC $62.34
- ROIV $8.73
- 52 Week High
- TTC $100.93
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- TTC 59.27
- ROIV 54.55
- Support Level
- TTC $73.15
- ROIV $10.71
- Resistance Level
- TTC $77.14
- ROIV $11.58
- Average True Range (ATR)
- TTC 1.69
- ROIV 0.29
- MACD
- TTC 0.56
- ROIV 0.00
- Stochastic Oscillator
- TTC 76.44
- ROIV 62.16
About TTC Toro Company (The)
The Toro Co manufactures turf maintenance and landscaping equipment. The company produces reel and rotary riding products, trim cutting and walking mowers, greens rollers, turf sprayer equipment, underground irrigation systems, heavy-duty walk-behind mowers, and sprinkler systems used for professional turf and landscape maintenance and construction. Its products are marketed through a network of distributors and dealers to predominantly professional users maintaining turfs and sports fields such as golf courses. Its operating segments are Professional which generates a substantial part of its revenue, and Residential segment. The company also produces snow plowers and ice management products. Its key revenue generating market is the United States.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.